SYNERGY PHARMACEUTICALS DEL (SGYP) Stock Price, Forecast & Analysis
USA - NASDAQ:SGYP -
SGYP Key Statistics, Chart & Performance
The current stock price of SGYP is 0.03 null. In the past month the price decreased by -90.32%. In the past year, price decreased by -98.62%.
SGYP Latest News, Press Relases and Analysis
About SGYP
Company Profile
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant- irritable bowel syndrome. It is also engaged in developing receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals, Inc. is headquartered in New York, New York.
Company Info
SYNERGY PHARMACEUTICALS DEL
420 LEXINGTON AVENUE SUITE 2012
NEW YORK NY 10170
CEO: Troy Hamilton
Phone: 212-297-0020
SYNERGY PHARMACEUTICALS DEL / SGYP FAQ
Can you describe the business of SYNERGY PHARMACEUTICALS DEL?
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant- irritable bowel syndrome. It is also engaged in developing receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals, Inc. is headquartered in New York, New York.
Can you provide the latest stock price for SYNERGY PHARMACEUTICALS DEL?
The current stock price of SGYP is 0.03 null. The price decreased by -52% in the last trading session.
Does SYNERGY PHARMACEUTICALS DEL pay dividends?
SGYP does not pay a dividend.
How is the ChartMill rating for SYNERGY PHARMACEUTICALS DEL?
SGYP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is SGYP stock listed?
SGYP stock is listed on the Nasdaq exchange.
Is SYNERGY PHARMACEUTICALS DEL (SGYP) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SGYP.
What is SYNERGY PHARMACEUTICALS DEL worth?
SYNERGY PHARMACEUTICALS DEL (SGYP) has a market capitalization of 7.44M null. This makes SGYP a Nano Cap stock.
SGYP Technical Analysis
SGYP Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SGYP. SGYP has a medium profitability rating, but doesn't score so well on its financial health evaluation.
SGYP Financial Highlights
Over the last trailing twelve months SGYP reported a non-GAAP Earnings per Share(EPS) of -0.5900000000000001. The EPS increased by 49.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -332.11% | ||
| ROA | -165.36% | ||
| ROE | 142.67% | ||
| Debt/Equity | 0 |